New drugs in development for the treatment of diabetes.
Diabetes Spectrum. 2009; 22: 92.
Abstract
A variety of new agents are in development for the treatment of type 1 or type 2 diabetes. In addition to new dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 analogs, thiazolidinediones, glinides, and new insulin formulations, there are also unique peroxisome proliferator-activated receptor agonists, selective sodium glucose contransporter 2 inhibitors, and several other unique agents now in development.